HBM Healthcare Investments (Cayman) Ltd. 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:19 pm Unchanged | 2024-09-30 | 13G | Mineralys Therapeutics, Inc. MLYS | HBM Healthcare Investments (Cayman) Ltd. | 2,246,332 4.500% | 0 (Unchanged) | Filing |
| 2024-02-13 4:09 pm Purchase | 2023-12-31 | 13G | Mineralys Therapeutics, Inc. MLYS | HBM Healthcare Investments (Cayman) Ltd. | 2,246,332 5.500% | 2,246,332 (New Position) | Filing |